In a previous study of HSPGs, we showed that stromal syndecan 1 was an adverse prognostic factor for ovarian cancer and that syndecan 3 was unusually expressed by the vasculature (Davies et al, 2004). The gene discussed is SDC3; the disease is ovarian carcinoma.